Suzanne will take responsibility for Abcam’s licensing, legal, compliance and company secretary activities. The new role has been created to help Abcam achieve its global growth objectives, supporting the Company’s partnership and acquisition goals.
Suzanne brings a wealth of experience to Abcam with 20 years’ global legal, business and leadership experience within the life science industry. She previously held the role of executive director, legal at Actavis plc, where she had responsibility for the leadership of the legal function internationally. Her prior roles include legal director at Genzyme Therapeutics Ltd, general counsel at Phoqus Pharmaceuticals plc and group legal counsel and company secretary at LGC Ltd. Suzanne is a qualified solicitor and holds an LLB law degree from the University of Exeter and an MBA from the Open University.
Alan Hirzel, CEO of Abcam, commented: “We are delighted to welcome Suzanne to Abcam’s leadership team. Suzanne’s knowledge and experience within the life sciences industry will be a valuable asset to our company.”
To find out more, please visit www.abcam.com
*******
Contacts:
Abcam
Francesca Axe
T: +44 (0) 1223 69600
Media enquiries
Katie Odgaard
Zyme Communications
E: katie.odgaard@zymecommunications.com
T: +44 (0) 7787 502 947
_____________________________________
Abcam appoints Suzanne Smith as Chief Legal Officer and Company Secretary
29 June 2015
Abcam plc, a global leader in the supply of life science research tools, announces that it has appointed Suzanne Smith in the new role of Chief Legal Officer and Company Secretary, based at Abcam’s headquarters in Cambridge, UK, effective from 6 July 2015. Accordingly, Jeff Iliffe will resign from the role of Company Secretary with effect from the same date.